Gene edit­ing de­liv­ery biotech GenEd­it part­ners with Genen­tech, rais­es an­oth­er $24M

Gene edit­ing still needs bet­ter de­liv­ery sys­tems, more than half a dozen years af­ter Kun­woo Lee re­calls CRISPR pi­o­neer Jen­nifer Doud­na telling at­ten­dees at a con­fer­ence that “de­liv­ery, de­liv­ery, de­liv­ery” is the key chal­lenge to mak­ing the promis­ing in­no­va­tion a broad­er re­al­i­ty.

Around that time, Lee re­ceived his bio­med­ical en­gi­neer­ing PhD from UC Berke­ley, the famed in­sti­tu­tion where Doud­na’s No­bel-win­ning re­search was con­duct­ed, and in 2016, he co-found­ed the Bay Area biotech GenEd­it in the hopes of ad­dress­ing the de­liv­ery chal­lenge.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER